Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,499 papers from all fields of science
Search
Sign In
Create Free Account
cycletanide sulfate
Known as:
cicletanine sulfate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyridines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
[Lack of effect of cicletanine and its sulfoconjugated metabolite on the thiazide receptor expressed in Xenopus oocytes].
A. Monroy
,
C. Plata
,
G. Gamba
,
M. Droy-Lefaix
,
R. Garay
Archives des maladies du coeur et des vaisseaux
1999
Corpus ID: 30685603
UNLABELLED Although the renal receptor at which cicletanine acts is unknown, cicletanine was assumed to act like thiazide…
Expand
1995
1995
Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat.
Ricardo P. Garay
,
Clelia Rosati
,
+4 authors
Richard Vistelle
European Journal of Pharmacology
1995
Corpus ID: 4540604
1993
1993
Opposite effects of cell growth factors and cicletanine sulfate on the sodium-independent [Cl-/HCO3-] exchange in cultured vascular smooth muscle.
K. Fanous
,
C. Nazaret
,
N. Senn
,
E. Decoopman-Morin
,
M. Allard
,
R. Garay
American Journal of Hypertension
1993
Corpus ID: 26050106
Cicletanine sulfate was tested on bicarbonate-dependent pHi changes in cultured vascular smooth muscle (A10 line). Cicletanine…
Expand
1992
1992
Cicletanine sulfate: inhibition of anion transport systems and natriuretic activity
R. Garay
,
C. Rosati
,
C. Nazaret
,
A. Esanu
,
T. Tarrade
,
P. Braquet
Naunyn-Schmiedeberg's Archives of Pharmacology
1992
Corpus ID: 22479504
SummaryIn contrast with cicletanine, its urinary sulfoconjugate metabolite (cicletanine sulfate) was active on membrane ion…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE